{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:30:41Z","timestamp":1784205041884,"version":"3.55.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-5582"],"award-info":[{"award-number":["IIRP-2023-5582"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.108949","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:22:28Z","timestamp":1757607748000},"page":"108949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Integrating molecular imaging with near-infrared theranostics to improve early detection and therapy of Alzheimer's disease"],"prefix":"10.1016","volume":"165","author":[{"given":"Gaurav","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1086-4316","authenticated-orcid":false,"given":"Kalpana","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7869-6541","authenticated-orcid":false,"given":"Avanish","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3762-7574","authenticated-orcid":false,"given":"Devendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0005","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"Alzheimer's disease facts and figures","volume":"19","author":"Better","year":"2023","journal-title":"Alzheimer's Dementia : J. Alzheimer's Assoc."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J. Prevention Alzheimer's Dis."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0015","first-page":"149","article-title":"Prevalence, distribution, treatment, andmodern methods forin vitro diagnosisof Alzheimer\u2019s disease in India:Challenges and future prospective, Thai","volume":"46","author":"Sopan Nangare","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"8 Suppl","key":"10.1016\/j.bioorg.2025.108949_bb0020","first-page":"S177","article-title":"Economic burden of Alzheimer disease and managed care considerations","volume":"26","author":"Wong","year":"2020","journal-title":"Am. J. Manag. Care"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5582\/ddt.2025.01055","article-title":"The pTau217\/A\u03b2<sub>1-42<\/sub> plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer&apos;s disease","volume":"19","author":"Hu","year":"2025","journal-title":"Drug Discoveries Therapeut."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108949_bb0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/JCMA.0000000000001252","article-title":"A 2025 update on treatment strategies for the Alzheimer's disease spectrum","volume":"88","author":"Wu","year":"2025","journal-title":"J. Chin. Med. Assoc. : JCMA"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neumar.2025.100078","article-title":"Blood biomarkers for clinical applications in Alzheimer's disease: A narrative review","volume":"2","author":"Li","year":"2025","journal-title":"NeuroMarkers"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0045","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108949_bb0050","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1021\/acschemneuro.5c00207","article-title":"Alzheimer\u2019s Disease: A Review of Molecular Mechanisms and Therapeutic Implications by Targeting Sirtuins, Caspases, and GSK-3","volume":"16","author":"Pandya","year":"2025","journal-title":"ACS Chem. Neurosci."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108949_bb0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.disamonth.2010.06.001","article-title":"Alzheimer disease","volume":"56","author":"Castellani","year":"2010","journal-title":"Dis.-A-month : DM"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"24","key":"10.1016\/j.bioorg.2025.108949_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive Review on Alzheimer's Disease: Causes and Treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108949_bb0070","article-title":"Neuroimaging in Alzheimer's Disease for Early Diagnosis: A Comprehensive Review","volume":"15","author":"Aramadaka","year":"2023","journal-title":"Cureus"},{"issue":"51","key":"10.1016\/j.bioorg.2025.108949_bb0075","doi-asserted-by":"crossref","first-page":"47504","DOI":"10.1021\/acsomega.2c05609","article-title":"Preclinical Models for Alzheimer\u2019s Disease: Past, Present, and Future Approaches","volume":"7","author":"Akhtar","year":"2022","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2796.2004.01381.x","article-title":"MRI and CSF studies in the early diagnosis of Alzheimer\u2019s disease","volume":"256","author":"de Leon","year":"2004","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bioorg.2025.108949_bb0085","article-title":"MRI segmentation of the human brain: challenges, methods, and applications","volume":"2015","author":"Despotovi\u0107","year":"2015","journal-title":"Computat. Math. Methods Med."},{"key":"10.1016\/j.bioorg.2025.108949_bb0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuroimage.2018.12.018","article-title":"Protein aggregation linked to Alzheimer's disease revealed by saturation transfer MRI","volume":"188","author":"Chen","year":"2019","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmri.28067","article-title":"Magnetic Resonance Imaging Versus Computed Tomography for Three-Dimensional Bone Imaging of Musculoskeletal Pathologies: A Review","volume":"56","author":"Florkow","year":"2022","journal-title":"J. Magn. Resonance Imaging : JMRI"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0100","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006213","article-title":"Brain imaging in Alzheimer disease","volume":"2","author":"Johnson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bioorg.2025.108949_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jneumeth.2013.11.016","article-title":"Machine learning on brain MRI data for differential diagnosis of Parkinson\u2019s disease and Progressive Supranuclear Palsy","volume":"222","author":"Salvatore","year":"2014","journal-title":"J. Neurosci. Methods"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108949_bb0110","article-title":"Revolutionizing Medical Imaging: The Transformative Role of Artificial Intelligence in Diagnostics and Treatment","volume":"15","author":"Giansanti","year":"2025","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0115","article-title":"\u00b9\u2078F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)","volume":"1","author":"Smailagic","year":"2015","journal-title":"Cochrane Database System. Rev."},{"key":"10.1016\/j.bioorg.2025.108949_bb0120","doi-asserted-by":"crossref","unstructured":"C. Marcus, E. Mena, R.M. Subramaniam, Brain PET in the diagnosis of Alzheimer's disease, Clin. Nucl. Med. 39(10) (2014) e413-22; quiz e423-6.","DOI":"10.1097\/RLU.0000000000000547"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108949_bb0125","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/s41380-023-02215-8","article-title":"The use of neuroimaging techniques in the early and differential diagnosis of dementia","volume":"28","author":"Chouliaras","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00259-015-3228-x","article-title":"Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"43","author":"Morris","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108949_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1474-4422(11)70123-5","article-title":"Clinical amyloid imaging in Alzheimer\u2019s disease","volume":"10","author":"Herholz","year":"2011","journal-title":"The Lancet. Neurol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0140","first-page":"55","article-title":"Positron emission tomography (PET) imaging with (18)F-based radiotracers","volume":"2","author":"Alauddin","year":"2012","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108949_bb0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11910-014-0500-6","article-title":"Tau PET imaging in Alzheimer's disease","volume":"14","author":"Okamura","year":"2014","journal-title":"Curr. Neurol. Neurosci. Reports"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.semnuclmed.2020.12.008","article-title":"PET Agents in Dementia: An Overview","volume":"51","author":"van Waarde","year":"2021","journal-title":"Semin. Nucl. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020290","article-title":"The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET","volume":"13","author":"Mohammadi","year":"2023","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108949_bb0160","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cpet.2017.03.001","article-title":"PET Imaging for Early Detection of Alzheimer's Disease: From Pathologic to Physiologic Biomarkers","volume":"12","author":"Bao","year":"2017","journal-title":"PET Clinics"},{"key":"10.1016\/j.bioorg.2025.108949_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115382","article-title":"Small-molecule theranostics in Alzheimer's disease","volume":"255","author":"Sarabia-Vallejo","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042110","article-title":"Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring","volume":"22","author":"van Oostveen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108949_bb0180","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/acschemneuro.8b00093","article-title":"Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling","volume":"9","author":"Murugan","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0185","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108949_bb0190","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.2967\/jnumed.114.139550","article-title":"Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology","volume":"55","author":"Hashimoto","year":"2014","journal-title":"J. Nucl. Med.\u202f: Off. Publ., Soc. Nucl. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0195","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab190","article-title":"Evaluation of [(18)F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies","volume":"3","author":"Tezuka","year":"2021","journal-title":"Brain Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108949_bb0200","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.sult.2020.08.011","article-title":"Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions","volume":"41","author":"Rowley","year":"2020","journal-title":"Semin. Ultrasound CT MR"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","article-title":"High-Contrast In\u00a0Vivo Imaging of Tau Pathologies in Alzheimer's and Non-Alzheimer's Disease Tauopathies","volume":"109","author":"Tagai","year":"2021","journal-title":"Neuron"},{"issue":"23","key":"10.1016\/j.bioorg.2025.108949_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238948","article-title":"Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies","volume":"21","author":"Silva","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108949_bb0215","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2967\/jnumed.112.117341","article-title":"Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease","volume":"54","author":"Okamura","year":"2013","journal-title":"J. Nucl. Med.\u202f: Off. Publ., Soc. Nucl. Med."},{"issue":"Pt 4","key":"10.1016\/j.bioorg.2025.108949_bb0220","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awr038","article-title":"18F-THK523: a novel in vivo tau imaging ligand for Alzheimer\u2019s disease","volume":"134","author":"Fodero-Tavoletti","year":"2011","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bioorg.2025.108949_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108676","article-title":"(S)-[18F]THK5117 brain uptake is associated with A\u03b2 plaques and MAO-B enzyme in a mouse model of Alzheimer's disease","volume":"196","author":"Alzghool","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2025.108949_bb0230","doi-asserted-by":"crossref","DOI":"10.1177\/1536012115624920","article-title":"Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807","volume":"15","author":"Declercq","year":"2016","journal-title":"Mol. Imaging"},{"issue":"13","key":"10.1016\/j.bioorg.2025.108949_bb0235","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2174\/1381612043384772","article-title":"Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain","volume":"10","author":"Mathis","year":"2004","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0240","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0245","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.115.164848","article-title":"18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease","volume":"57","author":"Harada","year":"2016","journal-title":"J. Nucl. Med.\u202f: Off. Publ., Soc. Nucl. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39227-x","article-title":"High sensitivity of asymmetric (18)F-THK5351 PET abnormality in patients with corticobasal syndrome","volume":"13","author":"Kurihara","year":"2023","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108949_bb0255","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93621","article-title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease","volume":"2","author":"Koronyo","year":"2017","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108949_bb0260","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","article-title":"Ocular indicators of Alzheimer's: exploring disease in the retina","volume":"132","author":"Hart","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0265","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.survophthal.2020.10.009","article-title":"Optical coherence tomography angiography in neuro-ophthalmology: Current clinical role and future perspectives","volume":"66","author":"Pujari","year":"2021","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sjopt.2014.09.016","article-title":"OCT: New perspectives in neuro-ophthalmology","volume":"29","author":"Rebolleda","year":"2015","journal-title":"Saudi J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108949_bb0275","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/jnnp-2020-325347","article-title":"Retinal imaging in Alzheimer's disease","volume":"92","author":"Cheung","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0280","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JAD-230055","article-title":"Deep Reinforcement Learning-Based Retinal Imaging in Alzheimer's Disease: Potential and Perspectives","volume":"94","author":"Hui","year":"2023","journal-title":"J. Alzheimer's Dis. : JAD"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108949_bb0285","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/bc200151q","article-title":"Theranostics: combining imaging and therapy","volume":"22","author":"Kelkar","year":"2011","journal-title":"Bioconjug. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108949_bb0290","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s00259-024-06690-1","article-title":"Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer's disease","volume":"51","author":"Zhou","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.bioorg.2025.108949_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2022.131481","article-title":"Detection of A\u03b2 oligomers in early Alzheimer\u2019s disease diagnose by in vivo NIR-II fluorescence imaging","volume":"358","author":"Li","year":"2022","journal-title":"Sensors Actuators B Chem."},{"key":"10.1016\/j.bioorg.2025.108949_bb0300","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/150952","article-title":"Small-molecule theranostic probes: a promising future in neurodegenerative diseases","volume":"2013","author":"Auli\u0107","year":"2013","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.108949_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117001","article-title":"A novel viscosity sensitive hemicyanine fluorescent dye for real-time imaging of amyloid-\u03b2 aggregation","volume":"281","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0310","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0003-2697(89)90046-8","article-title":"Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1","volume":"177","author":"Naiki","year":"1989","journal-title":"Anal. Biochem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0315","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/pr0605567","article-title":"Spectral properties of thioflavin T in solvents with different dielectric properties and in a fibril-incorporated form","volume":"6","author":"Maskevich","year":"2007","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0320","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.160696","article-title":"Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation","volume":"4","author":"Xue","year":"2017","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.bioorg.2025.108949_bb0325","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fbioe.2019.00487","article-title":"Recent Progress in NIR-II Contrast Agent for Biological Imaging","volume":"7","author":"Cao","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108949_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202200161","article-title":"Tailoring hydrophobicity of Thioflavin T to optimize A\u03b2 fibril bioimaging","volume":"3","author":"Zunbul","year":"2023","journal-title":"Adv. NanoBiomed Res."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0335","doi-asserted-by":"crossref","DOI":"10.1088\/2050-6120\/4\/3\/034010","article-title":"Combined thioflavin T-Congo red fluorescence assay for amyloid fibril detection","volume":"4","author":"Girych","year":"2016","journal-title":"Methods Appl. Fluoresc."},{"issue":"26","key":"10.1016\/j.bioorg.2025.108949_bb0340","doi-asserted-by":"crossref","first-page":"15294","DOI":"10.1073\/pnas.2534647100","article-title":"Imaging linear birefringence and dichroism in cerebral amyloid pathologies","volume":"100","author":"Jin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.micron.2008.10.002","article-title":"Optical properties of amyloid stained by Congo red: history and mechanisms","volume":"40","author":"Howie","year":"2009","journal-title":"Micron (Oxford, England : 1993)"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108949_bb0350","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/labinvest.3700714","article-title":"Physical basis of colors seen in Congo red-stained amyloid in polarized light","volume":"88","author":"Howie","year":"2008","journal-title":"Lab. Investigation; J. Tech. Methods Pathol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108949_bb0355","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s004280050471","article-title":"Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence","volume":"436","author":"Linke","year":"2000","journal-title":"Virchows Archiv.\u202f:Int. J. Pathol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108949_bb0360","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1046\/j.1440-1827.2003.01513.x","article-title":"Diagnosis of renal amyloidosis using Congo red fluorescence","volume":"53","author":"Sen","year":"2003","journal-title":"Pathol. Int."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108949_bb0365","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jnen\/61.9.797","article-title":"Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative","volume":"61","author":"Klunk","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"34","key":"10.1016\/j.bioorg.2025.108949_bb0370","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1002\/anie.200500845","article-title":"In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers","volume":"44","author":"Nesterov","year":"2005","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108949_bb0375","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1523\/JNEUROSCI.4456-03.2004","article-title":"Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain","volume":"24","author":"Okamura","year":"2004","journal-title":"J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2025.108949_bb0380","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1007\/s00259-007-0708-7","article-title":"Smart optical probes for near-infrared fluorescence imaging of Alzheimer\u2019s disease pathology","volume":"35","author":"Raymond","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108949_bb0385","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/anie.201104150","article-title":"Inhibition of beta-amyloid peptide aggregation by multifunctional carbazole-based fluorophores","volume":"51","author":"Yang","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108949_bb0390","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/ol100474b","article-title":"Cyanines as new fluorescent probes for DNA detection and two-photon excited bioimaging","volume":"12","author":"Feng","year":"2010","journal-title":"Org. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108949_bb0395","doi-asserted-by":"crossref","first-page":"13556","DOI":"10.1021\/acsomega.3c10417","article-title":"Recent Advances in Fluorescent Theranostics for Alzheimer's Disease: A Comprehensive Survey on Design, Synthesis, and Properties","volume":"9","author":"Francisco","year":"2024","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1946","article-title":"Advances in nanoprobes for molecular MRI of Alzheimer's disease","volume":"16","author":"Parekh","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bioorg.2025.108949_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113210","article-title":"Cognitive improvement and synaptic deficit attenuation by a multifunctional carbazole-based cyanine in AD mice model through regulation of Ca(2+)\/CaMKII\/CREB signaling pathway","volume":"327","author":"Chen","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bioorg.2025.108949_bb0410","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biomaterials.2016.03.047","article-title":"A theranostic agent for in\u00a0vivo near-infrared imaging of \u03b2-amyloid species and inhibition of \u03b2-amyloid aggregation","volume":"94","author":"Li","year":"2016","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108949_bb0415","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1039\/C7SC03974C","article-title":"Fluoro-substituted cyanine for reliable in vivo labelling of amyloid-\u03b2 oligomers and neuroprotection against amyloid-\u03b2 induced toxicity","volume":"8","author":"Li","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2025.108949_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102280","article-title":"Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models","volume":"51","author":"Iyaswamy","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0425","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s42826-023-00184-1","article-title":"Insight into the emerging and common experimental in-vivo models of Alzheimer's disease","volume":"39","author":"Dhapola","year":"2023","journal-title":"Lab. Animal Res."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108949_bb0430","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1021\/acsomega.8b00475","article-title":"Effective Theranostic Cyanine for Imaging of Amyloid Species in Vivo and Cognitive Improvements in Mouse Model","volume":"3","author":"Li","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.108949_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.121830","article-title":"Amyloid-\u03b2 oligomer targeted theranostic probes for in vivo NIR imaging and inhibition of self-aggregation and amyloid-\u03b2 induced ROS generation","volume":"224","author":"Wang","year":"2021","journal-title":"Talanta"},{"issue":"22","key":"10.1016\/j.bioorg.2025.108949_bb0440","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1039\/D3TB00082F","article-title":"Multifunctional theranostic carbazole-based cyanine for real-time imaging of amyloid-\u03b2 and therapeutic treatment of multiple pathologies in Alzheimer's disease","volume":"11","author":"Chen","year":"2023","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108949_bb0445","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/med.20188","article-title":"Curcumin and its analogues: potential anticancer agents","volume":"30","author":"Agrawal","year":"2010","journal-title":"Med. Res. Rev."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.108949_bb0450","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jchromb.2007.03.010","article-title":"Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS\/MS","volume":"853","author":"Yang","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0455","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/adt.2007.064","article-title":"Improving the solubility and pharmacological efficacy of curcumin by heat treatment","volume":"5","author":"Kurien","year":"2007","journal-title":"Assay Drug Develop. Technol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108949_bb0460","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"42","key":"10.1016\/j.bioorg.2025.108949_bb0465","doi-asserted-by":"crossref","first-page":"15257","DOI":"10.1021\/ja9047043","article-title":"Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits","volume":"131","author":"Ran","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0470","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11307-018-1213-z","article-title":"Near-infrared Fluorescence Ocular Imaging (NIRFOI) of Alzheimer's Disease","volume":"21","author":"Yang","year":"2019","journal-title":"Mol. Imaging Biol."},{"issue":"44","key":"10.1016\/j.bioorg.2025.108949_bb0475","doi-asserted-by":"crossref","first-page":"16397","DOI":"10.1021\/ja405239v","article-title":"Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer\u2019s disease","volume":"135","author":"Zhang","year":"2013","journal-title":"J. Am. Chem. Soc."},{"issue":"78","key":"10.1016\/j.bioorg.2025.108949_bb0480","doi-asserted-by":"crossref","first-page":"11550","DOI":"10.1039\/C4CC03731F","article-title":"A bifunctional curcumin analogue for two-photon imaging and inhibiting crosslinking of amyloid beta in Alzheimer\u2019s disease","volume":"50","author":"Zhang","year":"2014","journal-title":"Chem. Commun. (Camb.)"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25040863","article-title":"CRANAD-28: A Robust Fluorescent Compound for Visualization of Amyloid Beta Plaques","volume":"25","author":"Ran","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"31","key":"10.1016\/j.bioorg.2025.108949_bb0490","doi-asserted-by":"crossref","first-page":"9734","DOI":"10.1073\/pnas.1505420112","article-title":"Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer\u2019s disease","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108949_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27123879","article-title":"Curcumin Scaffold as a Multifunctional Tool for Alzheimer's Disease Research","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108949_bb0500","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1039\/C7SC02050C","article-title":"Tuning the stereo-hindrance of a curcumin scaffold for the selective imaging of the soluble forms of amyloid beta species","volume":"8","author":"Li","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2025.108949_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111585","article-title":"Development of novel theranostic agents for in vivo amyloid imaging and protective effects on human neuroblastoma cells","volume":"181","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010196","article-title":"Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology","volume":"22","author":"Shabbir","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0515","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/acschemneuro.6b00380","article-title":"Development of Phenothiazine-Based Theranostic Compounds That Act Both as Inhibitors of \u03b2-Amyloid Aggregation and as Imaging Probes for Amyloid Plaques in Alzheimer's Disease","volume":"8","author":"Dao","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108949_bb0520","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300705","article-title":"Current Small Molecule-Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics","volume":"19","author":"Sanghai","year":"2024","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108949_bb0525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JAD-130164","article-title":"Ferulic acid inhibits the transition of amyloid-\u03b242 monomers to oligomers but accelerates the transition from oligomers to fibrils","volume":"37","author":"Cui","year":"2013","journal-title":"J. Alzheimer's Dis. : JAD"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0530","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/ml3003605","article-title":"A Fluorescent Styrylquinoline with Combined Therapeutic and Diagnostic Activities against Alzheimer\u2019s and Prion Diseases","volume":"4","author":"Staderini","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0535","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/jnc.13887","article-title":"Pittsburgh Compound-B (PiB) binds amyloid \u03b2-protein protofibrils","volume":"140","author":"Yamin","year":"2017","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108949_bb0540","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.bpj.2011.01.058","article-title":"On the origin of the stronger binding of PIB over thioflavin T to protofibrils of the Alzheimer amyloid-\u03b2 peptide: a molecular dynamics study","volume":"100","author":"Wu","year":"2011","journal-title":"Biophys. J."},{"issue":"99","key":"10.1016\/j.bioorg.2025.108949_bb0545","doi-asserted-by":"crossref","first-page":"15792","DOI":"10.1039\/C4CC06029F","article-title":"Crown ethers attenuate aggregation of amyloid beta of Alzheimer's disease","volume":"50","author":"Tian","year":"2014","journal-title":"Chem. Commun."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0550","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1246\/bcsj.20190356","article-title":"Molecular Tools to Detect Alloforms of A\u03b2 and Tau: Implications for Multiplexing and Multimodal Diagnosis of Alzheimer\u2019s Disease","volume":"93","author":"Arora","year":"2020","journal-title":"Bull. Chem. Soc. Jpn."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108949_bb0555","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1039\/C6QI00268D","article-title":"A copper\u2013amyloid-\u03b2 targeted fluorescent chelator as a potential theranostic agent for Alzheimer's disease","volume":"3","author":"Yang","year":"2016","journal-title":"Inorganic Chem. Front."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108949_bb0560","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","article-title":"The binding of 2-(4\u2019-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component","volume":"23","author":"Klunk","year":"2003","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108949_bb0565","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.7150\/thno.94788","article-title":"Theranostics and artificial intelligence: new frontiers in personalized medicine","volume":"14","author":"Belge Bilgin","year":"2024","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020335","article-title":"The Future of Precision Medicine in the Cure of Alzheimer's Disease","volume":"11","author":"Arafah","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2025.108949_bb0575","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/978-1-61737-992-5_26","article-title":"Detecting amyloid-\u03b2 plaques in Alzheimer\u2019s disease","volume":"711","author":"Baltes","year":"2011","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.bioorg.2025.108949_bb0580","doi-asserted-by":"crossref","DOI":"10.2174\/0118746098359258250727103551","article-title":"Advances in Nanotechnology for Targeted Drug Delivery in Alzheimer\u2019s Disease","author":"Maheshwari","year":"2025","journal-title":"Curr. Aging Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108949_bb0585","first-page":"i","article-title":"Ethical Issues of Artificial Intelligence in Medicine and Healthcare","volume":"50","author":"Farhud","year":"2021","journal-title":"Iran. J. Public Health"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108949_bb0590","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrneurol.2013.216","article-title":"Alzheimer disease: [11C]PBB3--a new PET ligand that identifies tau pathology in the brains of patients with AD","volume":"9","author":"Wood","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108949_bb0595","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S1041610219002047","article-title":"[(18)F]FDDNP PET binding predicts change in executive function in a pilot clinical trial of geriatric depression","volume":"33","author":"Krause-Sorio","year":"2021","journal-title":"Int. Psychogeriatr."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108949_bb0600","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheimer\u2019s Dementia\u202f: J. Alzheimer\u2019s Assoc."},{"key":"10.1016\/j.bioorg.2025.108949_bb0605","first-page":"1504","article-title":"Synthesis of Benzimidazole based Scaffolds and Automated Radiosynthesis of [18F]-T808 PET Tracer","volume":"64","author":"Singh","year":"2023","journal-title":"J Nucl Med."},{"issue":"Suppl. 2","key":"10.1016\/j.bioorg.2025.108949_bb0610","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.rbp.2012.07.002","article-title":"New molecular targets for PET and SPECT imaging in neurodegenerative diseases","volume":"34","author":"Benadiba","year":"2012","journal-title":"Revista brasileira de psiquiatria (Sao Paulo, Brazil\u202f: 1999)"},{"issue":"Pt 6","key":"10.1016\/j.bioorg.2025.108949_bb0615","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/brain\/awu064","article-title":"Non-invasive assessment of Alzheimer\u2019s disease neurofibrillary pathology using 18F-THK5105 PET","volume":"137","author":"Okamura","year":"2014","journal-title":"Brain J. Neurol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108949_bb0620","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2967\/jnumed.115.163493","article-title":"Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models","volume":"57","author":"Brendel","year":"2016","journal-title":"J. Nucl. Med.: Off. Publ., Soc. Nucl. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108949_bb0625","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3988\/jcn.2022.18.4.437","article-title":"[(18)F]THK-5351 PET patterns in patients with Alzheimer's disease and negative amyloid PET findings","volume":"18","author":"Oh","year":"2022","journal-title":"J. Clin. Neurol. (Seoul, Korea)"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T20:30:12Z","timestamp":1760560212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":125,"alternative-id":["S0045206825008296"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108949","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating molecular imaging with near-infrared theranostics to improve early detection and therapy of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108949"}}